Investigation of glucocorticoid-induced side effects in patients with autoimmune diseases

Yakugaku Zasshi

Volumn 129, Issue 4, 2009, Pages 445-450

  Nakajima, Aya ^a   DOKi, Kosuke ^a,b   Homma, Masato ^a,b   Sagae, Terumi ^a   Saito, Reiko ^a   Ito, Satoshi ^b   Sumida, Takayuki ^b   Kohda, Yukinao ^a,b  

^a UNIVERSITY OF TSUKUBA HOSPITAL   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Autoimmune disease; Glucocorticoids (GC); Prednisolone; Side effect

Indexed keywords

ANTICOAGULANT AGENT; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; BISPHOSPHONIC ACID DERIVATIVE; COLECALCIFEROL; DIURETIC AGENT; FARNOQUINONE; HISTAMINE H2 RECEPTOR ANTAGONIST; HYPNOTIC AGENT; IRON; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISOLONE; PROTON PUMP INHIBITOR; SALAZOSULFAPYRIDINE; THYROID HORMONE; GLUCOCORTICOID;

ADULT; ADULT ONSET STILL DISEASE; AGED; ANCA ASSOCIATED VASCULITIS; ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; AUTOIMMUNE DISEASE; BEHCET DISEASE; CATARACT; CLINICAL FEATURE; DERMATOMYOSITIS; DRUG INDUCED DISEASE; FEMALE; GASTROINTESTINAL DISEASE; GASTROINTESTINAL SYMPTOM; GLAUCOMA; HUMAN; HYPERCHOLESTEROLEMIA; HYPERGLYCEMIA; HYPERLIPIDEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; INSOMNIA; MAJOR CLINICAL STUDY; MALE; MIXED CONNECTIVE TISSUE DISEASE; MOON FACE; OSTEOPOROSIS; OVERNUTRITION; PHARMACIST; PHYSICIAN; POLYMYOSITIS; RHEUMATOID ARTHRITIS; SCLERODERMA; SJOEGREN SYNDROME; SYNOVITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; THRUSH; TREATMENT DURATION; WEGENER GRANULOMATOSIS; APPETITE; CHEMICALLY INDUCED DISORDER; DOSE RESPONSE; DRUG EFFECT; MIDDLE AGED;

ADULT; AGED; AGED, 80 AND OVER; APPETITE; AUTOIMMUNE DISEASES; CANDIDIASIS, ORAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GLUCOCORTICOIDS; HUMANS; HYPERCHOLESTEROLEMIA; HYPERGLYCEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; MALE; MIDDLE AGED; PREDNISOLONE; SLEEP INITIATION AND MAINTENANCE DISORDERS; YOUNG ADULT;

EID: 66149157902     PISSN: 00316903     EISSN: 13475231     Source Type: Journal    
DOI: 10.1248/yakushi.129.445     Document Type: Article

References (15)

1. Suzuki Y., Ichikawa Y., "Selecting and Using Glucocorticoids, "Chap. 5, eds. by Yano S., Sato B., Nankodo, Tokyo, 2006, pp. 39-49.
2. Umehara C., "New Adrenocorticoids Therapy,"ed. by Umehara C., Japan Merck Banyu Co., Ltd., Tokyo, 1982, pp. 453-475.
3. Maxwell S.R., Moots R.J., Kendall M.J., Postgrad. Med. J., 70, 863-870 (1994).
4. Japanese Society of Hypertension Guidelines for the Management of Hypertension 2004:
5. Fardet L., Cabane J., Kettaneh A., Lebbe C., Flahault A., Rheumatology, 46, 1102-1106 (2007).
6. Wei L., MacDonald T. M., Walker B. R., Ann. Intern. Med., 141, 764-770 (2004).
7. Bjornadal L., Yin L., Granath F., Klareskog L., Ekbom A., J. Rheumatol., 31, 713-719 (2004).
8. Miyamoto K., "Steroids-Q&A for Instruction on Dosage and Administration," Fuji Medical Publication, Osaka, 2002, pp. 38-39.
9. Maeda J., Nihon-Iji-Shinpo, No. 3817, 107-108 (1997).
10. Mitsuhashi T., Nakai H., Saionji K., Rynsho- to-Kenkyu, 74, 72-75 (1997).
11. Ruiz J. O., Simmons R. L., Callender C. O., Kjellstrand C. M., Buselmeier T. J., Najarian J. S., Surgery, 73, 759-765 (1973).
12. Arner P., Gunnarsson R., Blomdahl S., Groth C. G., Diabetes Care, 6, 23-25 (1983).
13. HricikD.E., BartucciM.R., MoirE.J., Mayes J. T., Schulak J. A., Transplantation, 51, 374-377 (1991).
14. Sugihara M., Tsutsumi A., Sumida T., Naika, 97, 636-640 (2006).
15. Tahara T., Yoshioka N., "Guideline for Rheumatic Disease," Chap. B-3, eds. by Koike T., Sumida T., Shindan-to-Chiryosha Co., Ltd., Tokyo, 2005, pp. 186-191.